Progress Software: Aurora Cannabis Advances PM Resistance Research in Cultivation Techniques

Advancements in Cannabis Cultivation: Aurora Cannabis Leads with PM Resistance Research

Aurora Cannabis Inc., a prominent global player in the medical cannabis sector, announces significant progress in its efforts to combat powdery mildew (PM), a common and challenging disease affecting cannabis plants. Nearly a year after identifying a novel genetic source of resistance known as PM2, Aurora engages in multiple breeding trials to incorporate this resistance into elite cannabis strains. This initiative is crucial, as it ensures that the new cultivars not only resist PM but also retain the high-quality traits necessary for patients and consumers. The advancement in breeding techniques highlights Aurora's commitment to enhancing both the health of its plants and the overall quality of its products.

The company is currently transitioning from research to production trials at its Aurora Ridge manufacturing facility, marking a significant step toward the commercialization of PM-resistant cultivars. Lana Culley, Vice President of Innovation and International Operations at Aurora, underscores that this transition validates the company's scientific efforts and sets the stage for a transformative shift in cannabis cultivation. By successfully integrating PM2 resistance into its strains, Aurora aims to reduce the impact of plant diseases, which can lead to increased operational costs and compromised product quality. The research and development efforts are a testament to Aurora's dedication to leading the charge in cannabis innovation.

Aurora's research initiatives extend beyond its internal efforts, as the PM2 genetic marker technology is developed in partnership with the University of British Columbia and supported by funding from Genome British Columbia. This collaborative approach reflects the company's commitment to scientific rigor and innovation in the cannabis industry. As the production trials progress, Aurora plans to bring these PM-resistant cultivars to market later this year, positioning itself as a leader in plant health and operational efficiency. With patent applications pending in Canada, the United States, and Europe, Aurora is poised to set new standards in cannabis cultivation that could significantly benefit both existing and emerging markets.

In addition to its focus on PM resistance, Aurora highlights its participation in various prestigious conferences, where its research has garnered attention and recognition. This commitment to sharing knowledge and fostering innovation within the industry reinforces Aurora's role as a forward-thinking player in the cannabis space.

As Aurora Cannabis continues to innovate through advanced breeding techniques and rigorous research, it strengthens its production network and enhances its ability to meet the demands of an evolving market. The company's advancements not only contribute to the quality of cannabis products but also pave the way for a more resilient and sustainable industry.